Evidence map›Paper›PMID 26271011›Full record

ArticleMacromolecular bioscience2015

Self-Assembly of a Multifunctional Lipid With Core-Shell Dendrimer DNA Nanoparticles Enhanced Efficient Gene Delivery at Low Charge Ratios into RPE Cells.

Da Sun, Hiroshi Maeno, Maneesh Gujrati, Rebecca Schur, Akiko Maeda, Tadao Maeda, Krzysztof Palczewski, Zheng-Rong Lu

Open access · greenAbstract read
In one paragraph

Article in Macromolecular bioscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. How Advanced are Nanocarriers for Effective Subretinal Injection?International journal of nanomedicine · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Effective gene therapy of Stargardt disease with PEG-ECO/Molecular therapy. Nucleic acids · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse model.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Da SunDepartment of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, Ohio , 44140, USA.
Hiroshi MaenoDepartment of Ophthalmology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, 44140, USA.
Maneesh GujratiDepartment of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, Ohio , 44140, USA.
Rebecca SchurDepartment of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, Ohio , 44140, USA.
Akiko MaedaDepartment of Ophthalmology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, 44140, USA.
Tadao MaedaDepartment of Ophthalmology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, 44140, USA.
Krzysztof PalczewskiDepartment of Pharmacology, Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, 44140, USA.
Zheng-Rong LuDepartment of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, Ohio , 44140, USA. zxl125@case.edu.
Case Western Reserve University · US

Funding

Pharmacological Treatment of Retinal DiseasesR24EY021126 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI PALCZEWSKI, KRZYSZTOF · 2010 to 2014
$12.8M
NEI NIH HHS R24 EY021126NEI NIH HHS R24EY021126
6 · The paper itself

Abstract

Development of safe and effective gene delivery systems is essential in treating ocular genetic disorders. A hybrid nonviral system composed of a multifunctional lipid ECO and a G4 nanoglobule was designed for efficient gene delivery into RPE cells at low charge ratios. This system formed stable DNA nanoparticles at low N/P ratios, exhibited low cytotoxicity, and induced higher GFP expression in ARPE-19 cells at N/P = 6. The hybrid nanoparticles mediated significant reporter gene GFP expression ex-vivo in the retina from wild type C57 mice and in vivo in BALB/c mice. These hybrid nanoparticles are promising for in vitro and in vivo gene delivery at low charge ratios.

Indexed as

Gene Transfer TechniquesMaterials TestingAnimalsCell LineDendrimersDNAGenes, ReporterLipidsMiceMice, Inbred BALB CNanoparticlesRetinaDendrimersDNALipidsDNA plasmidECO lipidgene deliverynanoglobulesubretinal gene delivery

Identifiers

PMID26271011
PMCPMC4770799
OpenAlexW1605970019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.